1. Executive Summary |
2. Neurology Devices Market Introduction |
2.1. Global Neurology Devices Market – Taxonomy |
2.2. Global Neurology Devices Market –Definitions |
2.2.1. By Product |
2.2.2. By End User |
2.2.3. By Region |
3. Global Neurology Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Neurology Devices Market Dynamic Factors – Impact Analysis |
3.6. Global Neurology Devices Market – Competition Landscape |
4. Global Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Neurology Devices Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Neurostimulation Devices |
5.1.1. Spinal Cord Stimulation Devices |
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Deep Brain Stimulation Devices |
5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Sacral Nerve Stimulation Devices |
5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.1.4. Other Neurostimulation Devices |
5.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3. Market Opportunity Analysis |
5.2. Neurosurgery Devices |
5.2.1. Neuroendoscopes |
5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Stereotactic Systems |
5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3. Aneurysm Clips |
5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
5.2.4. Other Neurosurgery Devices |
5.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.4.3. Market Opportunity Analysis |
5.3. Interventional Neurology Devices |
5.3.1. Interventional/Surgical Simulators |
5.3.1.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.1.3. Market Opportunity Analysis |
5.3.2. Neurothrombectomy Devices |
5.3.2.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.2.3. Market Opportunity Analysis |
5.3.3. Carotid Artery Stents |
5.3.3.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3.3. Market Opportunity Analysis |
5.3.4. Embolic Coils |
5.3.4.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.4.3. Market Opportunity Analysis |
5.3.5. Support Devices |
5.3.5.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.3.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.5.3. Market Opportunity Analysis |
5.4. Cerebrospinal Fluid Management Devices |
5.4.1. CSF Shunt Devices |
5.4.1.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.1.3. Market Opportunity Analysis |
5.4.2. CSF Drainage Devices |
5.4.2.1. Market Analysis, 2017-2021 and Forecast, 2022 -2028 (Revenue, USD Mn) |
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.2.3. Market Opportunity Analysis |
6. Global Neurology Devices Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1. Hospitals |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ambulatory surgery centers |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Neurology clinics |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Neurology Devices Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Neurology Devices Market – Opportunity Analysis Index, By Product, By Application and Region, 2022 – 2028 |
8. North America Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Neurostimulation Devices |
8.1.1.1. Spinal Cord Stimulation Devices |
8.1.1.2. Deep Brain Stimulation Devices |
8.1.1.3. Sacral Nerve Stimulation Devices |
8.1.1.4. Other Neurostimulation Devices |
8.1.2. Neurosurgery Devices |
8.1.2.1. Neuroendoscopes |
8.1.2.2. Stereotactic Systems |
8.1.2.3. Aneurysm Clips |
8.1.2.4. Other Neurosurgery Devices |
8.1.3. Interventional Neurology Devices |
8.1.3.1. Interventional/Surgical Simulators |
8.1.3.2. Neurothrombectomy Devices |
8.1.3.3. Carotid Artery Stents |
8.1.3.4. Embolic Coils |
8.1.3.5. Support Devices |
8.1.4. Cerebrospinal Fluid Management Devices |
8.1.4.1. CSF Shunt Devices |
8.1.4.2. CSF Drainage Devices |
8.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Hospitals |
8.2.2. Ambulatory surgery centers |
8.2.3. Neurology clinics |
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028 |
8.5. North America Neurology Devices Market Dynamics – Trends |
9. Europe Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Neurostimulation Devices |
9.1.1.1. Spinal Cord Stimulation Devices |
9.1.1.2. Deep Brain Stimulation Devices |
9.1.1.3. Sacral Nerve Stimulation Devices |
9.1.1.4. Other Neurostimulation Devices |
9.1.2. Neurosurgery Devices |
9.1.2.1. Neuroendoscopes |
9.1.2.2. Stereotactic Systems |
9.1.2.3. Aneurysm Clips |
9.1.2.4. Other Neurosurgery Devices |
9.1.3. Interventional Neurology Devices |
9.1.3.1. Interventional/Surgical Simulators |
9.1.3.2. Neurothrombectomy Devices |
9.1.3.3. Carotid Artery Stents |
9.1.3.4. Embolic Coils |
9.1.3.5. Support Devices |
9.1.4. Cerebrospinal Fluid Management Devices |
9.1.4.1. CSF Shunt Devices |
9.1.4.2. CSF Drainage Devices |
9.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Hospitals |
9.2.2. Ambulatory surgery centers |
9.2.3. Neurology clinics |
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Russia |
9.3.7. Rest of Europe |
9.4. Europe Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028 |
9.5. Europe Neurology Devices Market Dynamics – Trends |
10. Asia-Pacific Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Neurostimulation Devices |
10.1.1.1. Spinal Cord Stimulation Devices |
10.1.1.2. Deep Brain Stimulation Devices |
10.1.1.3. Sacral Nerve Stimulation Devices |
10.1.1.4. Other Neurostimulation Devices |
10.1.2. Neurosurgery Devices |
10.1.2.1. Neuroendoscopes |
10.1.2.2. Stereotactic Systems |
10.1.2.3. Aneurysm Clips |
10.1.2.4. Other Neurosurgery Devices |
10.1.3. Interventional Neurology Devices |
10.1.3.1. Interventional/Surgical Simulators |
10.1.3.2. Neurothrombectomy Devices |
10.1.3.3. Carotid Artery Stents |
10.1.3.4. Embolic Coils |
10.1.3.5. Support Devices |
10.1.4. Cerebrospinal Fluid Management Devices |
10.1.4.1. CSF Shunt Devices |
10.1.4.2. CSF Drainage Devices |
10.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Hospitals |
10.2.2. Ambulatory surgery centers |
10.2.3. Neurology clinics |
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. China |
10.3.2. India |
10.3.3. Japan |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028 |
10.5. Asia-Pacific Neurology Devices Market Dynamics – Trends |
11. Latin America Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Neurostimulation Devices |
11.1.1.1. Spinal Cord Stimulation Devices |
11.1.1.2. Deep Brain Stimulation Devices |
11.1.1.3. Sacral Nerve Stimulation Devices |
11.1.1.4. Other Neurostimulation Devices |
11.1.2. Neurosurgery Devices |
11.1.2.1. Neuroendoscopes |
11.1.2.2. Stereotactic Systems |
11.1.2.3. Aneurysm Clips |
11.1.2.4. Other Neurosurgery Devices |
11.1.3. Interventional Neurology Devices |
11.1.3.1. Interventional/Surgical Simulators |
11.1.3.2. Neurothrombectomy Devices |
11.1.3.3. Carotid Artery Stents |
11.1.3.4. Embolic Coils |
11.1.3.5. Support Devices |
11.1.4. Cerebrospinal Fluid Management Devices |
11.1.4.1. CSF Shunt Devices |
11.1.4.2. CSF Drainage Devices |
11.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Hospitals |
11.2.2. Ambulatory surgery centers |
11.2.3. Neurology clinics |
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Neurology Devices Market – Opportunity Analysis Index, By Product, By End User and Country, 2022 – 2028 |
11.5. Latin America Neurology Devices Market Dynamics – Trends |
12. Middle East and Africa Neurology Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Neurostimulation Devices |
12.1.1.1. Spinal Cord Stimulation Devices |
12.1.1.2. Deep Brain Stimulation Devices |
12.1.1.3. Sacral Nerve Stimulation Devices |
12.1.1.4. Other Neurostimulation Devices |
12.1.2. Neurosurgery Devices |
12.1.2.1. Neuroendoscopes |
12.1.2.2. Stereotactic Systems |
12.1.2.3. Aneurysm Clips |
12.1.2.4. Other Neurosurgery Devices |
12.1.3. Interventional Neurology Devices |
12.1.3.1. Interventional/Surgical Simulators |
12.1.3.2. Neurothrombectomy Devices |
12.1.3.3. Carotid Artery Stents |
12.1.3.4. Embolic Coils |
12.1.3.5. Support Devices |
12.1.4. Cerebrospinal Fluid Management Devices |
12.1.4.1. CSF Shunt Devices |
12.1.4.2. CSF Drainage Devices |
12.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Hospitals |
12.2.2. Ambulatory surgery centers |
12.2.3. Neurology clinics |
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Neurology Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028 |
12.5. MEA Neurology Devices Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Abbott Laboratories |
13.2.2. B. BRAUN MELSUNGEN AG |
13.2.3. Boston Scientific Corporation |
13.2.4. Sanofi |
13.2.5. Integra LifeSciences Holdings Corporation |
13.2.6. Johnson & Johnson |
13.2.7. LivaNova PLC |
13.2.8. Medtronic Plc |
13.2.9. Magstim Co Ltd. |
13.2.10. Penumbra, Inc. |
13.2.11. Stryker Corporation |
14. Research Methodology |
15. Key Assumptions and Acronyms |